Innovent Biologics, Inc. (IVBXF)
11.01
-1.33
(-10.80%)
USD |
OTCM |
Sep 16, 16:00
Innovent Biologics Price : 11.01 for Sept. 16, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 16, 2026 | 11.01 | 11.01 | 11.01 | 11.01 | 781.00 |
| Sep 15, 2026 | 11.35 | 12.34 | 11.35 | 12.34 | 4086.00 |
| Sep 14, 2026 | 11.76 | 11.76 | 11.76 | 11.76 | 361.00 |
| Sep 11, 2026 | 11.01 | 12.31 | 11.01 | 11.76 | 1104.00 |
| Sep 10, 2026 | 12.36 | 12.36 | 12.00 | 12.00 | 777.00 |
| Sep 09, 2026 | 12.66 | 12.66 | 12.66 | 12.66 | 553.00 |
| Sep 08, 2026 | 13.18 | 13.18 | 13.18 | 13.18 | 6192.00 |
| Sep 04, 2026 | 13.00 | 13.11 | 13.00 | 13.11 | 4841.00 |
| Sep 03, 2026 | 12.84 | 12.84 | 12.84 | 12.84 | 145.00 |
| Sep 02, 2026 | 12.84 | 12.84 | 12.84 | 12.84 | 431.00 |
| Sep 01, 2026 | 13.99 | 13.99 | 12.84 | 12.84 | 1967.00 |
| Aug 31, 2026 | 14.27 | 14.27 | 14.27 | 14.27 | 592.00 |
| Aug 28, 2026 | 15.00 | 15.01 | 14.62 | 15.01 | 989.00 |
| Aug 27, 2026 | 14.20 | 14.20 | 14.20 | 14.20 | 558.00 |
| Aug 26, 2026 | 13.88 | 14.20 | 13.88 | 14.20 | 694.00 |
| Aug 25, 2026 | 13.30 | 13.30 | 13.30 | 13.30 | 1374.00 |
| Aug 24, 2026 | 12.70 | 13.61 | 12.70 | 13.61 | 1911.00 |
| Aug 21, 2026 | 12.80 | 12.92 | 11.80 | 11.80 | 5028.00 |
| Aug 20, 2026 | 12.41 | 12.41 | 12.41 | 12.41 | 500.00 |
| Aug 19, 2026 | 12.41 | 12.41 | 12.41 | 12.41 | 470.00 |
| Aug 18, 2026 | 12.79 | 12.79 | 11.47 | 12.41 | 1195.00 |
| Aug 17, 2026 | 12.37 | 12.37 | 12.37 | 12.37 | 1152.00 |
| Aug 14, 2026 | 12.37 | 12.37 | 12.37 | 12.37 | 753.00 |
| Aug 13, 2026 | 12.37 | 12.37 | 12.37 | 12.37 | 397.00 |
| Aug 12, 2026 | 12.37 | 12.37 | 12.37 | 12.37 | 114.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Ascletis Pharma, Inc. | 1.10 |
| CStone Pharmaceuticals Co. Ltd. | 0.9109 |
| RemeGen Co., Ltd. | 10.93 |
| InnoCare Pharma Ltd. | 1.55 |
| Adagene, Inc. | 3.17 |
Price Related Metrics
| PE Ratio | 110.39 |
| PS Ratio | 8.645 |
| Earnings Yield | 0.91% |
| Market Cap | 19.09B |
| Operating PE Ratio | 51.18 |
| Normalized PE Ratio | 108.11 |